NHI241220P110000
- 0.00
- 0.000.00%
National Health Investors Inc Newsroom
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Hold Rating, Announces Target Price $76
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Hold Rating
BofA Securities Maintains National Health Investors Inc(NHI.US) With Buy Rating, Cuts Target Price to $91
Wells Fargo Initiates National Health Investors Inc(NHI.US) With Hold Rating, Announces Target Price $86
Truist Financial Maintains National Health Investors Inc(NHI.US) With Hold Rating
Analysts Offer Insights on Real Estate Companies: National Health Investors (NHI) and Peakstone Realty Trust (PKST)
Hold Rating Maintained for National Health Investors Amid Financial Uncertainty and Strategic Challenges
BMO Capital Maintains National Health Investors Inc(NHI.US) With Buy Rating, Maintains Target Price $92
Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Downgrades National Health Investors Inc(NHI.US) to Hold Rating, Raises Target Price to $86
National Health Investors Downgraded to Equal Weight From Overweight at Wells Fargo
BofA Securities Initiates National Health Investors Inc(NHI.US) With Buy Rating, Announces Target Price $92
BMO Capital Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $92
National Health Investors Price Target Raised to $78.00/Share From $65.00 by Truist Securities
National Health Investors Analyst Ratings
Deutsche Bank Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $90
Deutsche Bank Raises Price Target on National Health Investors to $90 From $69, Keeps Buy Rating
Wells Fargo Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $81
KeyBanc Initiates National Health Investors Inc(NHI.US) With Hold Rating
Buy Rating Justified by National Health Investors' Strong Q2 Financials and Growth Prospects